$CYRX News

Keybanc Maintains Overweight on CryoPort, Raises Price Target to $17

Guggenheim Maintains Buy on CryoPort, Raises Price Target to $12

Needham Maintains Buy on CryoPort, Raises Price Target to $15

BTIG Maintains Buy on CryoPort, Raises Price Target to $17

Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript

Cryoport Inc (NASDAQ:CYRX) Reports Q1 2026 Revenue Beat Amid Wider Net Loss and Cautious Full-Year Outlook

Cryoport, Inc. 2026 Q1 - Results - Earnings Call Presentation

Cryoport Posts Revenue Beat In Q1 As Clinical Trial Support Hits All-Time High — 'A Strong Start To 2026'

CryoPort Raises FY2026 Sales Guidance from $190.000M-$194.000M to $192.000M-$196.000M vs $191.834M Est

CryoPort Q1 Adj. EPS $(0.25) Misses $(0.22) Estimate, Sales $47.800M Beat $44.862M Estimate

Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven

Craig-Hallum Initiates Coverage On CryoPort with Buy Rating, Announces Price Target of $15

Needham Maintains Buy on CryoPort, Raises Price Target to $13

Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript

Cryoport Inc (NASDAQ:CYRX) Reports Mixed Q4 2025 Results with Revenue Beat but Persistent Losses

Cryoport, Inc. 2025 Q4 - Results - Earnings Call Presentation

CryoPort Q4 Earnings Summary & Key Takeaways

CryoPort Sees FY2026 Sales $190.000M-$194.000M vs $189.493M Est.

CryoPort Q4 Adj. EPS $(0.17) Beats $(0.21) Estimate, Sales $45.450M Beat $42.921M Estimate.

CryoPort's Earnings Outlook